INMD - InMode Ltd Debt to Book Capitalization Ratio

Corporate company logo of InMode Ltd. (INMD)

The historical price action of InMode Ltd. (INMD) demonstrates the market trends of a company with a metric of 0.01. The business focuses on creating durable aesthetic devices with minimal plastic usage. This approach is complemented by its status as a technological pioneer in RF surgery, driven by high R&D expenditures. Protection against competitors is ensured by strict certifications and a patent portfolio, creating a sustainable market barrier.

InMode Ltd. - INMD Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Flagship merchandise of InMode MD

This ratio determines the proportion of borrowed funds within the equity structure, allowing for an assessment of financial autonomy and default risk during external shocks. Analyzing the historical total debt-to-book capital ratio of InMode Ltd. (INMD), we see absolute business stability, which confirms management's strategy of maintaining a debt-free development model alongside high margins for aesthetic technologies.

Competitors of InMode Ltd.

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|Picard Medical - Debts to Book Capitalization|Debts to Book Value Surmodics Inc SRDX|Debt to Book Value SENS (senseonics.com)|NPCE - Debts to Book Capitalization|Debt to Book Value Tactile Systems Technology Inc. TCMD|SNWV - Debt to Book Capital|Outset Medical - Debts to Book Capitalization|Electromed (ELMD) - Debts to Net Assets|Debts to Book Capitalization LNSR|Debt to Book Value AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Debt to Book Value|Debt to Net Assets Ratio BDMD (bairdmed.com)|EDAP TMS - Debt to Book Capitalization Ratio|Debt to Book Value Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio